Form 4: UnitedHealth Director Michele Hooper Boosts Stake

UnitedHealth Group Director Michele J. Hooper acquired 292 shares of common stock through dividend equivalents on vested deferred stock units.

Summary

• Michele J. Hooper, a Director of UnitedHealth Group Inc. (UNH), acquired 292 shares of common stock.
• The acquisition occurred on March 17, 2026.
• These shares represent dividend equivalents paid on vested deferred stock units.
• The dividend equivalents were immediately vested and are subject to the same terms as the underlying deferred stock units.
• Following this transaction, Ms. Hooper beneficially owns 41,586 shares of UnitedHealth Group common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine, slightly positive event, as it indicates a director's continued accumulation of company stock, albeit through a non-discretionary compensation mechanism.

Positives

• Director Michele J. Hooper increased her beneficial ownership in UnitedHealth Group by 292 shares.
• The acquired shares are immediately vested, indicating immediate full ownership rights.

Industry Context

StockSavvy.ai notes that insider transactions, even those related to compensation like dividend equivalents, provide transparency into executive holdings. For a large, established healthcare company like UnitedHealth Group, such routine filings are common and reflect standard compensation practices for directors.

Related Party Transactions

• Acquisition of 292 shares of common stock by Director Michele J. Hooper from UnitedHealth Group Inc. as dividend equivalents on vested deferred stock units.

Stakeholder Impact

• Shareholders: Provides transparency into director ownership and aligns director interests with shareholders.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary acquisition of shares by a director through dividend equivalents. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It merely reflects a standard compensation mechanism and a slight increase in insider ownership, which is generally neutral to slightly positive but not a strong catalyst for a 'buy' or 'sell' decision.

Keywords

UnitedHealth Group, UNH, Michele Hooper, Director, Insider Transaction, Form 4, Stock Ownership, Dividend Equivalents, Deferred Stock Units